Jefferies Financial Group Inc. Dynavax Technologies Corp Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$13.09 - $14.98 $1.32 Million - $1.51 Million	-101,100 Reduced 51.66%	94,600 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $1.9 Million - $2.25 Million	150,000 Added 328.23%	195,700 $2.89 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $450,145 - $601,869	45,700 New	45,700 $590,000
Q4 2022 Sep 21, 2023	SELL	$10.27 - $13.29 $400,221 - $517,911	-38,970 Reduced 85.27%	6,730 $71,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $69,117 - $89,441	6,730 New	6,730 $71,000

274

129M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.66B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.